Nuzenio

Cell Therapy Advances

Cell Therapy Advances news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Cartesian Therapeutics Advances RNA Cell Therapy Pipeline; Wedbush Sets $38 Price Target - RTTNewsRTTNews · Mon, 10 Aug 2026 13:38:00 GMT Hopstem Closes First Series C Financing to Advance iPSC Neural Cell Therapy - citybizcitybiz · Mon, 10 Aug 2026 12:56:43 GMT CAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer Advances - The American Journal of Managed CareThe American Journal of Managed Care · Sat, 08 Aug 2026 23:42:43 GMT Phase I Trial Evaluates Allogeneic CD70-Targeted CAR T-Cell Therapy in Advanced Renal Cell Carcinoma - The ASCO PostThe ASCO Post · Wed, 05 Aug 2026 14:32:11 GMT APPOS 2026: Advances in CAR T-Cell Therapy and Toxicity Management - OncodailyOncodaily · Mon, 03 Aug 2026 19:50:56 GMT EVERSANA Selected by Innovacell as Commercialization Partner to Advance Novel Cell Therapy ICEF15 in the United States - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT Aspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson's Disease - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 13:38:00 GMTCartesian Therapeutics Advances RNA Cell Therapy Pipeline; Wedbush Sets $38 Price Target - RTTNews

Mon, 10 Aug 2026 12:56:43 GMTHopstem Closes First Series C Financing to Advance iPSC Neural Cell Therapy - citybiz

Sat, 08 Aug 2026 23:42:43 GMTCAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer Advances - The American Journal of Managed Care

Wed, 05 Aug 2026 14:32:11 GMTPhase I Trial Evaluates Allogeneic CD70-Targeted CAR T-Cell Therapy in Advanced Renal Cell Carcinoma - The ASCO Post

Mon, 03 Aug 2026 19:50:56 GMTAPPOS 2026: Advances in CAR T-Cell Therapy and Toxicity Management - Oncodaily

Thu, 30 Jul 2026 07:00:00 GMTEVERSANA Selected by Innovacell as Commercialization Partner to Advance Novel Cell Therapy ICEF15 in the United States - PR Newswire

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Cell Therapy7 live mentions CAR T5 live mentions Advance4 live mentions Oncology4 live mentions Therapy3 live mentions Wedbush Sets2 live mentions Hopstem Closes First2 live mentions Series C Financing2 live mentions Neural Cell Therapy2 live mentions Biomarkers2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cell Therapy Advances.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.